Towards Breast Cancer Vaccines, Progress and Challenges

Area of Science:

• Oncology
• Immunology
• Vaccinology

Background:

• Breast cancer is a leading cause of cancer death in women, with significant lifetime diagnosis risk.
• Current treatments like surgery, radiotherapy, and chemotherapy have limitations, including adverse effects and relapse.
• Preventive measures include healthy lifestyle, physical activity, weight control, and smoking cessation.

Purpose of the Study:

• To explore the development of breast cancer vaccines as an immunotherapy strategy.
• To highlight the potential of vaccines in achieving long-lasting anticancer responses with minimal side effects.

Main Methods:

• Review of current research and clinical trials on breast cancer vaccines.
• Focus on immunotherapy approaches to stimulate the immune system against breast cancer.

Main Results:

• No breast cancer vaccines are currently approved for clinical use.
• One vaccine (NeuVax) has completed Phase III clinical trials.
• Several preventive and therapeutic breast cancer vaccines are in various developmental stages.

Conclusions:

• Breast cancer vaccine development is a rapidly advancing field.
• Immunotherapy, particularly vaccines, holds significant promise for future breast cancer treatment.
• Effective breast cancer vaccines are anticipated in the near future due to ongoing advancements.